Platelet Concentration Systems Market is expected to gain promising growth by 2030

Regenerative injection therapy that is capable of promoting the normal healing mechanism of the body is widely known as platelet rich plasma (PRP). Platelet rich plasma refers to an autologous blood plasma fraction that has been loaded with platelets utilizing high-end equipment. This method is also a non-surgical choice of treatment for wound healing, urology, ophthalmology, neurosurgery, ENT, dentistry, sports medicine, and orthopedics. It is also used in maxillofacial, cardiothoracic, and cosmetic surgeries. Such extensive use is likely to work in the favor of the global platelet concentration systems market in the near future.

Get Sample Copy of this Report @

Increased Adoption of the Treatment Method for Treating Sports Injuries to Drive Demand

At the point of care facilities, platelet concentration systems are engineered in such a way that it is able to make platelet-rich plasma from a limited volume of a patient’s blood sample in a secure and timely manner. The fragile buffy coat is kept as it is in such concentrated structures by centrifugal action that provides a high platelet yield. This buffy coat is suspended in plasma before being returned to the patient. The density of platelets will differ from four to eight times based on the method utilized in the preparation of PRP. In addition to that, several devices that are found in the market today are able to collect platelet-poor plasma, which can then be administered to patients as an autologous fibrin item for topical homeostasis. Given the growing utilization of PRP therapy in sports medicine and technological breakthroughs, the global platelet concentration systems market is estimated to observe high growth in the years to come.

The growing adoption of PRP therapy in sports medicine and high occurrence of musculoskeletal injuries are likely to emerge as the major factors for the expansion of the global platelet concentration systems market. In accordance with the findings of European Injury Data Base, around 4.5 million people aged 15 years and over are treated for sports injuries in different EU hospitals every year. The utilization of technologically sophisticated platelet concentration systems in the formulation of autologous blood concentrate is likely to augur well for the global platelet concentration systems market.

Check Table of Contents of this Report @

Author: Rohit Bhisey

As Head of Marketing at TMR Research, Rohit brings to the table over a decade of experience in market research and Internet marketing. His dedication, perseverance, and passion for perfection have enabled him to achieve immense success in his field. Rohit is an expert at formulating new business plans and strategies to help boost web traffic. His interests lie in writing news articles on technology,healthcare and business.

Leave a Reply

%d bloggers like this: